SPONSOR
Hansoh BioMedical R&D Company
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 3
NCT06763159 Phase 1
Recruiting
A Study of HS-20124 in Patients with Advanced Solid Tumors
Solid Cancer
NCT06855069 Phase 3
Recruiting
HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
Ovarian Cancer
NCT06892379 Phase 1
Recruiting
A Study of HS-20110 in Participants With Advanced Solid Tumors
Solid Tumors
NCT06498479 Phase 3
Recruiting
ARTEMIS-008:HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
Small Cell Lung Cancer